home *** CD-ROM | disk | FTP | other *** search
- Path: sparky!uunet!ferkel.ucsb.edu!taco!hsdndev!yale!yale.edu!qt.cs.utexas.edu!cs.utexas.edu!zaphod.mps.ohio-state.edu!cis.ohio-state.edu!news.sei.cmu.edu!drycas.club.cc.cmu.edu!cantaloupe.srv.cs.cmu.edu!das-news.harvard.edu!spdcc!dyer
- From: dyer@spdcc.com (Steve Dyer)
- Newsgroups: alt.drugs
- Subject: Re: Butyrophenones and Phenothiazines
- Message-ID: <1992Nov15.212342.9502@spdcc.com>
- Date: 15 Nov 92 21:23:42 GMT
- References: <1992Nov13.021518.20287@u.washington.edu> <1992Nov13.155311.10903@spdcc.com> <1992Nov14.040052.26698@u.washington.edu>
- Organization: S.P. Dyer Computer Consulting, Cambridge MA
- Lines: 16
-
- In article <1992Nov14.040052.26698@u.washington.edu> lamontg@stein.u.washington.edu (Lamont Granquist) writes:
- >Sorry, I thought that Haldol was one of the newer ones (if its not then I
- >may very well be wrong). The ones I'm thinking of have a different
- >affinity for the D3 receptor than the older ones like chlorpromazine,
- >and it was hypothesized that this might have something to do with the
- >lower reported frequency of tardive dyskinesia...
-
- For whatever reason these new ones haven't yet been observed to cause TD,
- haloperidol ain't one of them. It's been around for almost 30 years, and
- is one of the most classical of the classical neuroleptics. (That is, its
- screening in animal studies back then seemed to select for drugs with all
- the side effects we now associate with the "classical neuroleptics".)
-
- --
- Steve Dyer
- dyer@ursa-major.spdcc.com aka {ima,harvard,rayssd,linus,m2c}!spdcc!dyer
-